Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Endo Health Solutions Inc    ENDP

ENDO HEALTH SOLUTIONS INC (ENDP)
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Senate Panel Seeks Info From J&J, Endo, Others Over Concern On Painkiller Marketing -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/09/2012 | 08:44pm CEST

The Senate Finance Committee is looking into possible links between three drug companies and nonprofit medical groups, citing concerns about the groups' advocacy of painkillers, Reuters reported Wednesday.

The panel sent letters to Johnson & Johnson (JNJ), Endo Pharmaceuticals Holdings Inc. (>> Endo Pharmaceuticals Holdings Inc) and Purdue Pharma LP and seven medical groups seeking documents about their financial connections, Reuters reported.

Sen. Max Baucus (D., Mont.), the committee's chairman, said in a statement that "painkillers have an important role in health care when prescribed and used properly, but pushing misinformation on consumers to boost profits is not only wrong, it's dangerous," Reuters reported.

Reuters said officials at the three drug companies weren't immediately available for comment.

Full story at http://www.reuters.com/article/2012/05/09/us-usa-painkillers-investigation-idUSBRE84811420120509

-Dow Jones Newswires; 212-416-2900

Stocks mentioned in the article : Endo Pharmaceuticals Holdings Inc
Stocks mentioned in the article
ChangeLast1st jan.
ENDO HEALTH SOLUTIONS INC --End-of-day quote.
JOHNSON & JOHNSON -0.97% 122.25 Delayed Quote.-11.45%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ENDO HEALTH SOLUTIONS INC
05/18ENDO INTERNATIONAL : Open Letter on the Opioid Abuse Crisis
PU
05/15Florida and Texas Are Among Latest States to Sue Opioid Painkiller Companies
DJ
05/02NEW FRONT ON OPIOID LITIGATION : Suits Over Rising Premiums
DJ
05/02Indivior's first-quarter profit slips, shares fall on top drug let-down
RE
04/30ENDO INTERNATIONAL PLC : Blog Exposure - Endo International to Acquire Somerset ..
AC
03/23Indivior loses another case in battle to protect opioid addiction drug
RE
01/24City Files Opioid Lawsuit -- WSJ
DJ
01/23New York City Sues Companies Over Opioid Abuse
DJ
01/23New York City sues drug companies over opioid epidemic
RE
01/19Delaware sues opioid manufacturers, distributors over epidemic
RE
More news
Financials ($)
Sales 2018 2 742 M
EBIT 2018 1 139 M
Net income 2018 -285 M
Debt 2018 7 519 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019 8,88
EV / Sales 2018 3,25x
EV / Sales 2019 3,23x
Capitalization 1 401 M
Technical analysis trends ENDO HEALTH SOLUTIONS INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 21
Average target price 8,44 $
Spread / Average Target 35%
EPS Revisions
Managers
NameTitle
Paul V. Campanelli President, Chief Executive Officer & Director
Roger H. Kimmel Chairman
Terrance J. Coughlin Chief Operating Officer & Executive Vice President
Blaise Coleman Chief Financial Officer & Executive Vice President
Nancy J. Hutson Independent Director